This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paterson, D. L.
Right arrow Articles by Yu, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paterson, D. L.
Right arrow Articles by Yu, V. L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2001, p. 2206-2212, Vol. 39, No. 6
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.6.2206-2212.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum beta -Lactamases: Implications for the Clinical Microbiology Laboratory

David L. Paterson,1,2 Wen-Chien Ko,3 Anne Von Gottberg,4 Jose Maria Casellas,5 Lutfiye Mulazimoglu,6 Keith P. Klugman,4 Robert A. Bonomo,7 Louis B. Rice,7 Joseph G. McCormack,2 and Victor L. Yu1,*

Infectious Disease Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania1; Department of Medicine, University of Queensland, Brisbane, Australia2; Department of Medicine, National Cheng Kung University Medical College, Tainan, Taiwan3; South African Institute of Medical Research, Johannesburg, South Africa4; Departmento de Infectologia y Microbiologia, Sanatorio San Lucas, Buenos Aires, Argentina5; Department of Microbiology, Marmara University, Istanbul, Turkey6; and Infectious Disease Section, VA Medical Center, Cleveland, Ohio7

Received 18 December 2000/Returned for modification 30 January 2001/Accepted 20 March 2001

Although extended-spectrum beta-lactamases (ESBLs) hydrolyze cephalosporin antibiotics, some ESBL-producing organisms are not resistant to all cephalosporins when tested in vitro. Some authors have suggested that screening klebsiellae or Escherichia coli for ESBL production is not clinically necessary, and when most recently surveyed the majority of American clinical microbiology laboratories did not make efforts to detect ESBLs. We performed a prospective, multinational study of Klebsiella pneumoniae bacteremia and identified 10 patients who were treated for ESBL-producing K. pneumoniae bacteremia with cephalosporins and whose infecting organisms were not resistant in vitro to the utilized cephalosporin. In addition, we reviewed 26 similar cases of severe infections which had previously been reported. Of these 36 patients, 4 had to be excluded from analysis. Of the remaining 32 patients, 100% (4 of 4) patients experienced clinical failure when MICs of the cephalosporin used for treatment were in the intermediate range and 54% (15 of 28) experienced failure when MICs of the cephalosporin used for treatment were in the susceptible range. Thus, it is clinically important to detect ESBL production by klebsiellae or E. coli even when cephalosporin MICs are in the susceptible range (<=  8 µg/ml) and to report ESBL-producing organisms as resistant to aztreonam and all cephalosporins (with the exception of cephamycins).

* Corresponding author. Mailing address: Infectious Disease Division, VA Medical Center, University Dr. C, Pittsburgh, PA 15240. Phone: (412) 688-6179. Fax: (412) 688-6950. E-mail: vly+{at}pitt.edu.

Journal of Clinical Microbiology, June 2001, p. 2206-2212, Vol. 39, No. 6
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.6.2206-2212.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kohner, P. C., Robberts, F. J. L., Cockerill, F. R. III, Patel, R. (2009). Cephalosporin MIC Distribution of Extended-Spectrum-{beta}-Lactamase- and pAmpC-Producing Escherichia coli and Klebsiella Species. J. Clin. Microbiol. 47: 2419-2425 [Abstract] [Full Text]  
  • Bush, K., Jacoby, G. A., Amicosante, G., Bonomo, R. A., Bradford, P., Cornaglia, G., Garau, J., Giamarellou, H., Jarlier, V., Martinez-Martinez, L., Miriagou, V., Palzkill, T., Pascual, A., Rodriguez-Bano, J., Rossolini, G. M., Sougakoff, W., Vatopoulos, A. (2009). Comment on: Redefining extended-spectrum {beta}-lactamases: balancing science and clinical need. J Antimicrob Chemother 64: 212-213 [Full Text]  
  • Chin, B. S., Seo, W. Y., Paterson, D. L., Potoski, B. A., Peleg, A. Y. (2009). Cefepime MIC Breakpoint Resettlement in Gram-Negative Bacteria. Antimicrob. Agents Chemother. 53: 337-338 [Full Text]  
  • Grossman, R. F. (2009). Hospital-Acquired and Ventilator-Associated Pneumonia. ACCP Pulmonary Med Brd Rev 25: 391-400 [Full Text]  
  • Donaldson, H., McCalmont, M., Livermore, D. M., Rooney, P. J., Ong, G., McHenry, E., Campbell, R., McMullan, R. (2008). Evaluation of the VITEK(R)2 AST N-054 test card for the detection of extended-spectrum {beta}-lactamase production in Escherichia coli with CTX-M phenotypes. J Antimicrob Chemother 62: 1015-1017 [Abstract] [Full Text]  
  • Farber, J., Moder, K.-A., Layer, F., Tammer, I., Konig, W., Konig, B. (2008). Extended-Spectrum Beta-Lactamase Detection with Different Panels for Automated Susceptibility Testing and with a Chromogenic Medium. J. Clin. Microbiol. 46: 3721-3727 [Abstract] [Full Text]  
  • MacGowan, A. P., on behalf of the BSAC Working Parties on Resistanc, (2008). Clinical implications of antimicrobial resistance for therapy. J Antimicrob Chemother 62: ii105-ii114 [Abstract] [Full Text]  
  • Tumbarello, M., Sali, M., Trecarichi, E. M., Leone, F., Rossi, M., Fiori, B., De Pascale, G., D'Inzeo, T., Sanguinetti, M., Fadda, G., Cauda, R., Spanu, T. (2008). Bloodstream Infections Caused by Extended-Spectrum-{beta}-Lactamase- Producing Escherichia coli: Risk Factors for Inadequate Initial Antimicrobial Therapy. Antimicrob. Agents Chemother. 52: 3244-3252 [Abstract] [Full Text]  
  • Bhat, S. V., Peleg, A. Y., Lodise, T. P. Jr., Shutt, K. A., Capitano, B., Potoski, B. A., Paterson, D. L. (2007). Failure of Current Cefepime Breakpoints To Predict Clinical Outcomes of Bacteremia Caused by Gram-Negative Organisms. Antimicrob. Agents Chemother. 51: 4390-4395 [Abstract] [Full Text]  
  • Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A. (2007). Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 3471-3484 [Full Text]  
  • Zhu, L.-X., Zhang, Z.-W., Liang, D., Jiang, D., Wang, C., Du, N., Zhang, Q., Mitchelson, K., Cheng, J. (2007). Multiplex Asymmetric PCR-Based Oligonucleotide Microarray for Detection of Drug Resistance Genes Containing Single Mutations in Enterobacteriaceae. Antimicrob. Agents Chemother. 51: 3707-3713 [Abstract] [Full Text]  
  • Yang, K., Guglielmo, B J. (2007). Diagnosis and Treatment of Extended-Spectrum and AmpC {beta}-Lactamase-Producing Organisms. The Annals of Pharmacotherapy 41: 1427-1435 [Abstract] [Full Text]  
  • Turnidge, J., Paterson, D. L. (2007). Setting and Revising Antibacterial Susceptibility Breakpoints. Clin. Microbiol. Rev. 20: 391-408 [Abstract] [Full Text]  
  • Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D'Inzeo, T., Fadda, G., Cauda, R., Spanu, T. (2007). Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-{beta}-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment. Antimicrob. Agents Chemother. 51: 1987-1994 [Abstract] [Full Text]  
  • Glupczynski, Y., Berhin, C., Bauraing, C., Bogaerts, P. (2007). Evaluation of a New Selective Chromogenic Agar Medium for Detection of Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae. J. Clin. Microbiol. 45: 501-505 [Abstract] [Full Text]  
  • Schmitt, J., Jacobs, E., Schmidt, H. (2007). Molecular characterization of extended-spectrum beta-lactamases in Enterobacteriaceae from patients of two hospitals in Saxony, Germany. J Med Microbiol 56: 241-249 [Abstract] [Full Text]  
  • Birkett, C. I., Ludlam, H. A., Woodford, N., Brown, D. F. J., Brown, N. M., Roberts, M. T. M., Milner, N., Curran, M. D. (2007). Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum {beta}-lactamases. J Med Microbiol 56: 52-55 [Abstract] [Full Text]  
  • Bethel, C. R., Hujer, A. M., Hujer, K. M., Thomson, J. M., Ruszczycky, M. W., Anderson, V. E., Pusztai-Carey, M., Taracila, M., Helfand, M. S., Bonomo, R. A. (2006). Role of Asp104 in the SHV {beta}-Lactamase. Antimicrob. Agents Chemother. 50: 4124-4131 [Abstract] [Full Text]  
  • Rodloff, A. C., Goldstein, E. J. C., Torres, A. (2006). Two decades of imipenem therapy. J Antimicrob Chemother 58: 916-929 [Abstract] [Full Text]  
  • Franklin, C., Liolios, L., Peleg, A. Y. (2006). Phenotypic Detection of Carbapenem-Susceptible Metallo-{beta}-Lactamase-Producing Gram-Negative Bacilli in the Clinical Laboratory.. J. Clin. Microbiol. 44: 3139-3144 [Abstract] [Full Text]  
  • Gavin, P. J., Suseno, M. T., Thomson, R. B. Jr., Gaydos, J. M., Pierson, C. L., Halstead, D. C., Aslanzadeh, J., Brecher, S., Rotstein, C., Brossette, S. E., Peterson, L. R. (2006). Clinical Correlation of the CLSI Susceptibility Breakpoint for Piperacillin- Tazobactam against Extended-Spectrum-{beta}-Lactamase-Producing Escherichia coli and Klebsiella Species.. Antimicrob. Agents Chemother. 50: 2244-2247 [Abstract] [Full Text]  
  • Anderson, D. J., Engemann, J. J., Harrell, L. J., Carmeli, Y., Reller, L. B., Kaye, K. S. (2006). Predictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae.. Antimicrob. Agents Chemother. 50: 1715-1720 [Abstract] [Full Text]  
  • Tumbarello, M., Spanu, T., Sanguinetti, M., Citton, R., Montuori, E., Leone, F., Fadda, G., Cauda, R. (2006). Bloodstream Infections Caused by Extended-Spectrum-{beta}-Lactamase-Producing Klebsiella pneumoniae: Risk Factors, Molecular Epidemiology, and Clinical Outcome. Antimicrob. Agents Chemother. 50: 498-504 [Abstract] [Full Text]  
  • Thomas, K., Weinbren, M. J., Warner, M., Woodford, N., Livermore, D. (2006). Activity of mecillinam against ESBL producers in vitro. J Antimicrob Chemother 57: 367-368 [Full Text]  
  • Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
  • Szabo, D., Bonomo, R. A., Silveira, F., Pasculle, A. W., Baxter, C., Linden, P. K., Hujer, A. M., Hujer, K. M., Deeley, K., Paterson, D. L. (2005). SHV-Type Extended-Spectrum Beta-Lactamase Production Is Associated with Reduced Cefepime Susceptibility in Enterobacter cloacae. J. Clin. Microbiol. 43: 5058-5064 [Abstract] [Full Text]  
  • Livermore, D. M., Hawkey, P. M. (2005). CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 56: 451-454 [Abstract] [Full Text]  
  • DiNubile, M. J., Chow, J. W., Satishchandran, V., Polis, A., Motyl, M. R., Abramson, M. A., Teppler, H. (2005). Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal Infections. Antimicrob. Agents Chemother. 49: 3217-3221 [Abstract] [Full Text]  
  • Winstanley, T. G., Parsons, H. K., Horstkotte, M. A., Sobottka, I., Sturenburg, E. (2005). Phenotypic detection of {beta}-lactamase-mediated resistance to oxyimino-cephalosporins in Enterobacteriaceae: evaluation of the Mastascan Elite Expert System. J Antimicrob Chemother 56: 292-296 [Abstract] [Full Text]  
  • Endimiani, A., Luzzaro, F., Brigante, G., Perilli, M., Lombardi, G., Amicosante, G., Rossolini, G. M., Toniolo, A. (2005). Proteus mirabilis Bloodstream Infections: Risk Factors and Treatment Outcome Related to the Expression of Extended-Spectrum {beta}-Lactamases. Antimicrob. Agents Chemother. 49: 2598-2605 [Abstract] [Full Text]  
  • Black, J. A., Moland, E. S., Thomson, K. S. (2005). AmpC Disk Test for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC {beta}-Lactamases. J. Clin. Microbiol. 43: 3110-3113 [Abstract] [Full Text]  
  • Zaoutis, T. E., Goyal, M., Chu, J. H., Coffin, S. E., Bell, L. M., Nachamkin, I., McGowan, K. L., Bilker, W. B., Lautenbach, E. (2005). Risk Factors for and Outcomes of Bloodstream Infection Caused by Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella Species in Children. Pediatrics 115: 942-949 [Abstract] [Full Text]  
  • Linscott, A. J., Brown, W. J. (2005). Evaluation of Four Commercially Available Extended-Spectrum Beta-Lactamase Phenotypic Confirmation Tests. J. Clin. Microbiol. 43: 1081-1085 [Abstract] [Full Text]  
  • (2005). Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am. J. Respir. Crit. Care Med. 171: 388-416 [Full Text]  
  • Jacoby, G. A., Munoz-Price, L. S. (2005). The New {beta}-Lactamases. NEJM 352: 380-391 [Full Text]  
  • Masterton, R. G., Kuti, J. L., Turner, P. J., Nicolau, D. P. (2005). The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe. J Antimicrob Chemother 55: 71-77 [Abstract] [Full Text]  
  • Weinbren, M. J., Borthwick, M. A. (2005). Rapid detection of extended-spectrum {beta}-lactamase (ESBL)-producing organisms in blood culture. J Antimicrob Chemother 55: 131-132 [Full Text]  
  • Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., Choe, K.-W. (2004). Bloodstream Infections Due to Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy. Antimicrob. Agents Chemother. 48: 4574-4581 [Abstract] [Full Text]  
  • Kang, C.-I., Pai, H., Kim, S.-H., Kim, H.-B., Kim, E.-C., Oh, M.-d., Choe, K.-W. (2004). Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type {beta}-lactamase. J Antimicrob Chemother 54: 1130-1133 [Abstract] [Full Text]  
  • Bonnefoy, A., Dupuis-Hamelin, C., Steier, V., Delachaume, C., Seys, C., Stachyra, T., Fairley, M., Guitton, M., Lampilas, M. (2004). In vitro activity of AVE1330A, an innovative broad-spectrum non-{beta}-lactam {beta}-lactamase inhibitor. J Antimicrob Chemother 54: 410-417 [Abstract] [Full Text]  
  • Jeong, S. H., Bae, I. K., Lee, J. H., Sohn, S. G., Kang, G. H., Jeon, G. J., Kim, Y. H., Jeong, B. C., Lee, S. H. (2004). Molecular Characterization of Extended-Spectrum Beta-Lactamases Produced by Clinical Isolates of Klebsiella pneumoniae and Escherichia coli from a Korean Nationwide Survey. J. Clin. Microbiol. 42: 2902-2906 [Abstract] [Full Text]  
  • Maglio, D., Ong, C., Banevicius, M. A., Geng, Q., Nightingale, C. H., Nicolau, D. P. (2004). Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli at Various Inocula. Antimicrob. Agents Chemother. 48: 1941-1947 [Abstract] [Full Text]  
  • Rodriguez-Bano, J., Navarro, M. D., Romero, L., Martinez-Martinez, L., Muniain, M. A., Perea, E. J., Perez-Cano, R., Pascual, A. (2004). Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients. J. Clin. Microbiol. 42: 1089-1094 [Abstract] [Full Text]  
  • Tumbarello, M., Citton, R., Spanu, T., Sanguinetti, M., Romano, L., Fadda, G., Cauda, R. (2004). ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother 53: 277-282 [Abstract] [Full Text]  
  • Queenan, A. M., Foleno, B., Gownley, C., Wira, E., Bush, K. (2004). Effects of Inoculum and {beta}-Lactamase Activity in AmpC- and Extended-Spectrum {beta}-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates Tested by Using NCCLS ESBL Methodology. J. Clin. Microbiol. 42: 269-275 [Abstract] [Full Text]  
  • Samaha-Kfoury, J. N, Araj, G. F (2003). Recent developments in {beta} lactamases and extended spectrum {beta} lactamases. BMJ 327: 1209-1213 [Full Text]  
  • Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A., the International Klebsiella Study Group,, (2003). Extended-Spectrum {beta}-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type {beta}-Lactamases. Antimicrob. Agents Chemother. 47: 3554-3560 [Abstract] [Full Text]  
  • De Gheldre, Y., Avesani, V., Berhin, C., Delmee, M., Glupczynski, Y. (2003). Evaluation of Oxoid combination discs for detection of extended-spectrum {beta}-lactamases. J Antimicrob Chemother 52: 591-597 [Abstract] [Full Text]  
  • Hanson, N. D. (2003). AmpC {beta}-lactamases: what do we need to know for the future?. J Antimicrob Chemother 52: 2-4 [Full Text]  
  • Canton, R., Loza, E., Del Carmen Conejo, M., Baquero, F., Martinez-Martinez, L. (2003). Quality Control for {beta}-Lactam Susceptibility Testing with a Well-Defined Collection of Enterobacteriaceae and Pseudomonas aeruginosa Strains in Spain. J. Clin. Microbiol. 41: 1912-1918 [Abstract] [Full Text]  
  • Byington, C. L., Rittichier, K. K., Bassett, K. E., Castillo, H., Glasgow, T. S., Daly, J., Pavia, A. T. (2003). Serious Bacterial Infections in Febrile Infants Younger Than 90 Days of Age: The Importance of Ampicillin-Resistant Pathogens. Pediatrics 111: 964-968 [Abstract] [Full Text]  
  • Poirel, L., Heritier, C., Podglajen, I., Sougakoff, W., Gutmann, L., Nordmann, P. (2003). Emergence in Klebsiella pneumoniae of a Chromosome-Encoded SHV {beta}-Lactamase That Compromises the Efficacy of Imipenem. Antimicrob. Agents Chemother. 47: 755-758 [Abstract] [Full Text]  
  • Coudron, P. E., Hanson, N. D., Climo, M. W. (2003). Occurrence of Extended-Spectrum and AmpC Beta-Lactamases in Bloodstream Isolates of Klebsiella pneumoniae: Isolates Harbor Plasmid-Mediated FOX-5 and ACT-1 AmpC Beta-Lactamases. J. Clin. Microbiol. 41: 772-777 [Abstract] [Full Text]  
  • Navon-Venezia, S., Hammer-Munz, O., Schwartz, D., Turner, D., Kuzmenko, B., Carmeli, Y. (2003). Occurrence and Phenotypic Characteristics of Extended-Spectrum {beta}-Lactamases among Members of the Family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and Evaluation of Diagnostic Tests. J. Clin. Microbiol. 41: 155-158 [Abstract] [Full Text]  
  • Mutnick, A. H, Kirby, J. T, Jones, R. N (2003). CANCER Resistance Surveillance Program: Initial Results from Hematology-Oncology Centers in North America. The Annals of Pharmacotherapy 37: 47-56 [Abstract] [Full Text]  
  • Leverstein-van Hall, M. A., Fluit, A. C., Paauw, A., Box, A. T. A., Brisse, S., Verhoef, J. (2002). Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 Automated Instruments for Detection of Extended-Spectrum Beta-Lactamases in Multiresistant Escherichia coli and Klebsiella spp.. J. Clin. Microbiol. 40: 3703-3711 [Abstract] [Full Text]  
  • Tsay, R.-W., Siu, L. K., Fung, C.-P., Chang, F.-Y. (2002). Characteristics of Bacteremia Between Community-Acquired and Nosocomial Klebsiella pneumoniae Infection: Risk Factor for Mortality and the Impact of Capsular Serotypes as a Herald for Community-Acquired Infection. Arch Intern Med 162: 1021-1027 [Abstract] [Full Text]  
  • Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., Kim, E.-C. (2002). Bloodstream Infections by Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome. Antimicrob. Agents Chemother. 46: 1481-1491 [Abstract] [Full Text]  
  • Thomson, K. S., Moland, E. S. (2001). Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum beta -Lactamase-Producing Enterobacteriaceae. Antimicrob. Agents Chemother. 45: 3548-3554 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»